Prevalence of Sarcopenia in Patients Admitted to ICU and Its Progression During Hospitalization.
试验速览
- 阶段
- 不适用
- 状态
- Enrolling By Invitation
- 发起方
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Prevalence of sarcopenia at the time of ICU admission.
研究概览
简要总结
This is a prospective, observational study at the ICU of Hospital Mútua de Terrassa, running from May to December 2025. The primary goal is to determine the prevalence of sarcopenia in adult patients requiring more than 48 hours of mechanical ventilation. Sarcopenia is assessed using the SARC-F score, impedanciometry, and quadriceps ultrasound. Secondary aims include tracking the development of ICU-Acquired Weakness (ICU-AW) using the MRC score. All data is collected anonymously after obtaining informed consent.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Older than 18 years old.
- •Expected duration of mechanical ventilation (MV) exceeding 48 hours.
排除标准
- •Refusal to participate.
- •Mechanical ventilation not exceeding 48 hours.
- •Do-not-resuscitate (DNR) orders or limitations of therapeutic effort upon admission.
结局指标
主要结局
Prevalence of sarcopenia at the time of ICU admission.
时间窗: Baseline at admission to ICU
Describe the prevalence of sarcopenia at the time of ICU admission in patients with an expected duration of mechanical ventilation (MV) exceeding 48 hours.
次要结局
- Detecting patients who develop ICU-Acquired Weakness (ICU-AW) and/or prolonged mechanical ventilation weaning(From ICU admission to 30 days follow-up)
- Detecting the appearance of other complications(From admission to 30 days follow up)